Corneal stromal cells selectively inhibit production of anti-inflammatory cytokines by activated T cells

Clinical and Experimental Immunology

Volumn 136, Issue 2, 2004, Pages 200-206

  Holan V ^a,b   Vitova A ^a,b   Pindjakova J ^a,b   Krulova M ^a,b   Zajicova A ^a,b   Filipec, M ^b  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cornea; Cytokines; Eye; Immunoregulation; Inflammation

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; MITOGENIC AGENT;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL STIMULATION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA STROMA; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXPLANT; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; COCULTURE TECHNIQUES; CONCANAVALIN A; CORNEAL STROMA; CULTURE TECHNIQUES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES;

EID: 17044458411     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02457.x     Document Type: Article

References (37)

1. Medawar PB. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948; 29:58-69.
2. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol 1977; 25:1-54.
3. Ferguson TA, Green DR, Griffith TS. Cell death and immune privilege. Int Rev Immunol 2002; 21:153-72.
4. 1 lymphocyte-induced immune deviation. J Immunol 1977; 118:809-14.
5. Stein-Streilein J, Streilein JW. Anterior chamber-associted immune deviation (ACAID): regulation, biological relevance, and implication for therapy. Int Rev Immunol 2002; 21:123-52.
6. Streilein JW, Stein-Streilein J. Does innate immune privilege exist? J Leukoc Biol 2000; 67:479-87.
7. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270:1189-92.
8. Lee HO, Herndon JM, Barreiro R, Griffith TS, Ferguson TA. TRAIL: a mechanism of tumor surveillance in an immune privileged site. J Immunol 2002; 169:4739-44.
9. Skelsey ME, Mellon J, Niederkorn JY. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol 2001; 166:4327-33.
10. Taylor AW. Immunoregulation of the ocular effector responses by soluble factors in aqueous humor. Reg Immunol 1994; 6:52-7.
11. Niederkorn JY. The immune privilege of corneal allografts. Transplantation 1999; 67:1503-8.
12. Sonoda A, Sonoda Y, Muramatu R, Streilein JW, Usui M. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts. Invest Ophthalmol Vis Sci 2000; 41:790-808.
13. Holáň V, Hašková Z, Filipec M. Transplantation immunity and tolerance in the eye. Rejection and acceptance of orthotopic corneal allografts in mice. Transplantation 1996; 62:1050-4.
14. Dighiero P, Behar-Cohen F, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in bovine corneal endothelial cells and keratocytes in vitro after lipopolysaccharide and cytokines stimulation. Invest Ophthalmol Vis Sci 1997; 38:2045-52.
15. O'Brien WJ, Heimann T, Tsao LS, Seet BT, McFadden G, Taylor JL. Regulation of nitric oxide synthase 2 in rabbit corneal cells. Invest Ophthalmol Vis Sci 2001; 42:713-9.
16. Holáň V, Krulová M, Zajícová A, Pindjaková J. Nitric oxide as a regulatory and effector molecule in the immune system. Mol Immunol 2001; 3:989-95.
17. Wilson SE, He YG, Lloyd SA. EGF, EGF receptor, basic FGF, TGF β-1 and IL-1α messenger RNA production in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci 1992; 33:1756-65.
18. Sakamoto S, Inada K. Human corneal epithelial, stromal and endothelial cells produce IL-6. Acta Soc Ophthalmol Jpn 1992; 96:702-9.
19. Yamagami H, Yamagami S, Inoki T, Amano S, Miyata K. The effect of proinflammatory cytokines on cytokine-chemokine gene expression profiles in the human corneal endothelium. Invest Ophthalmol Vis Sci 2003; 44:514-20.
20. Kennedy M, Kim KH, Harten B et al. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci 1997; 38:2483-91.
21. Burbach GJ, Naik SM, Harten JB et al. Interleukin-18 expression and modulation in human corneal epithelial cells. Curr Eye Res 2001; 23:64-8.
22. He GY, Mellon J, Niederkorn JY. The effect of oral immunization on corneal allograft survival. Transplantation 1996; 61:920-6.
23. + T cells. J Immunol 1998; 161: 3237-41.
24. Hori J, Streilein JW. Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium. Invest Ophthalmol Vis Sci 2003; 44:658-64.
25. Mi P, Gregerson DS, Kawashima H. Local regulation of immune responses: corneal endothelial cells alter T cell activation and cytokine production. Cytokine 2000; 12:253-64.
26. Mills CD. Molecular basis of 'suppressor' macrophages: arginine metabolism via the nitric oxide synthetase pathway. J Immunol 1991; 146:2719-23.
27. van der Veen RC, Dietlin TA, Gray JD, Gilmore W. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell Immunol 2000; 199:43-9.
28. + T cells. Annu Rev Immunol 1994; 12:635-73.
29. Sassani JW, Zagon IS, McLauglin PJ. Opioid growth factor modulation of corneal epithelium: uppers and downers. Curr Eye Res 2003; 26:249-62.
30. Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol 1994; 153:1982-9.
31. Takase H, Sugita S, Rhee DJ et al. The presence of macrophage migration inhibitory factor in human trabecular meshwork and its upregulatory effects on the T helper 1 cytokine. Invest Ophthalmol Vis Sci 2002; 43:2691-6.
32. Seo SK, Gebhardt BM, Lim HY et al. Murine keratocytes function as antigen-presenting cells. Eur J Immunol 2001; 31:3318-28.
33. Mo JS, Streilein JW. Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS. Eur J Immunol 2001; 31:3806-15.
34. Stumpf TH, Shimeld C, Easty DL, Hill TJ. Cytokine production in a murine model of recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci 2001; 42:372-8.
35. McClellan SA, Huang X, Barrett RP, Van Rooijen N, Hazlett LD. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance of pro- and anti-inflammatory cytokines in BALB/c mice. J Immunol 2003; 170:5219-27.
36. Thakur A, Xue M, Stapleton F, Lloyd AR, Wakefield D, Willcox MD. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2002; 70:2187-97.
37. Torres PF, Kijlstra A. The role of cytokines in corneal immunopathology. Ocular Immunol Inflamm 2001; 9:9-24.